Michael Crossman Honigberg MD MPP
Cardiologist at Massachusetts General Hospital
Join to View Full Profile
55 Fruit StreetBoston, MA 02114
Phone+1 617-726-1843
Dr. Honigberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Cardiovascular Disease, 2017 - 2020
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2014 - 2017
Harvard Medical SchoolClass of 2014
Princeton UniversityAB, Public Policy, Summa cum laude, Phi Beta Kappa, 2004 - 2008
Certifications & Licensure
MA State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
National Board of EchocardiographyEchocardiography
Publications & Presentations
PubMed
- Sex Differences in the Association Between Lipoprotein(a) and Cardiovascular Outcomes: The MGB Lp(a) Registry.Gurleen Kaur, Adam N Berman, David W Biery, Stephanie A Besser, Wanda Y Wu
Journal of the American Heart Association. 2025-04-16 - 1 citationsGenetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous Women.Vineetha Mathew, Raiyan R Khan, Amanda R Jowell, Qi Yan, Itsik Pe'er
Journal of the American College of Cardiology. 2025-04-15 - Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target.Art Schuermans, Michael C Honigberg
Nature Reviews. Cardiology. 2025-04-02
Journal Articles
- Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults with DiabetesMichael C Honigberg, Ravi B Patel, Javed Butler, Darren K Mcguire, JAMA Cardiology
- Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular DiseaseMichael C Honigberg, Darren K Mcguire, Muthiah Vaduganathan, JAMA Cardiology
Authored Content
- Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular DiseaseJune 2020
Press Mentions
$15 Million Granted for Groundbreaking Research on Cardiovascular-Kidney-Metabolic Syndrome in WomenApril 22nd, 2025- Researchers Receive Grant to Study Cardiovascular-Kidney-Metabolic Syndrome in WomenApril 22nd, 2025
- 22 Health Care Predictions for 2025 from Medical ResearchersDecember 31st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
